Skip to main content

COPD with Exacerbations – Use of Long-Acting Bronchodilator Therapy

CBE ID
0628
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
No
1.6 Measure Description

Percentage of patients 40 years and older with COPD exacerbations that are receiving a long acting bronchodilator

    Measure Specs
      General Information
      1.7 Measure Type
      1.3 Electronic Clinical Quality Measure (eCQM)
      1.8 Level of Analysis
      1.14 Numerator

      Patients with a refill for a long acting bronchodilator

      Time Window: 6 months

      1.15 Denominator

      Patients 40 years and older with COPD exacerbations

      Time Window: 12 months

      Exclusions

      Patients with a lung transplant; other indications for steroid use

      General exclusions:
      • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
      • Patients who have been in a skilled nursing facility in the last 3 months

      Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Pulmonary Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
      Steward Organization
      ActiveHealth Management
      Steward POC email
                Public Comments